Australian functional consumer brand Zuum launched an extra-strength strawberry energy gum in September 2026. The release kicks off a planned 10-product rollout across domestic and overseas retail networks.
The new variant expands the core Performance Energy Gum line. Zuum is targeting wider shelf space in convenience chains, pharmacies and online direct-to-consumer channels.
Expanding the functional gum lineup
Cool Mint, Extra Strength Arctic Mint, Spearmint and Watermelon already sit in the range. The strawberry gum sells through Zuum’s website alongside physical retail stockists.
Functional chewing gums deliver active ingredients like caffeine and vitamins through oral absorption. That format provides faster uptake without liquid volume, giving shoppers an alternative to ready-to-drink energy beverages and traditional confectionery.
Convenience and pharmacy distribution
Convenience stores and pharmacy banners serve as the primary distribution ground for impulse functional products across Australia. Checkout placement captures commuters and workers seeking quick alertness fixes.
For retailers, high-margin functional confectionery delivers strong sales density per square centimetre at front registers. The products challenge conventional mints and sugary gums, which face steady volume pressure from health-conscious consumers.
Competitive pressure in energy alternatives
Energy gum competes directly with canned energy drinks, caffeine pouches and functional tablets. While canned drinks dominate total volume, portable formats win on pocket-sized convenience and zero-sugar recipes.
Survival in functional confectionery requires steady sales velocity after opening promotional campaigns fade. Retail buyers routinely clear counter space of slow-moving stock keeping units.
Retail rollout timeline
Zuum established its mainstream retail footprint in 2024 when convenience operator 7-Eleven introduced the gum line to Australian stores. That partnership gave the brand national visibility across high-traffic urban and roadside locations.
Nine additional products will arrive before the end of the second half of 2026. The company is now negotiating broader listings in domestic pharmacy chains and selected international markets.
